Details of the Drug
General Information of Drug (ID: DMPT4WM)
Drug Name |
Cytosine Arabinose-5'-Phosphate
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
7075-11-8; Ara-5'-CMP; Ara-CMP; Cytarabine 5'-monophosphate; ((2R,3S,4S,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate; CYTOSINE ARABINOSE-5'-PHOSPHATE; AraCMP; Cytosine arabinoside monophosphate; Aracytidine 5'-phosphate; Cytosine arabinoside 5'MP; Aracytidine 5'-monophosphate; UNII-Y73692GHI4; Y73692GHI4; NSC 99445; 1-beta-D-Arabinofuranosylcytosine 5'-phosphate; Cytosine-beta-D-arabinofuranoside-5'-monophosphate; Cytosine beta-D-arabinofuranoside 5'-monophosphate
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 323.2 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -3.4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 5 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 8 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||